Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor in Diabetic Wound Healing
NCT02790957Phase 2Terminated
- Start
- Jun 2016
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic foot ulcer (DFU) comparing Plerixafor with Placebo (2 arms). Primary endpoint: Wound healing rate at 6 months. Started Jun 2016; status: terminated.
02
Drugs
plerixafor
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT02790957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02790957.